ProPublica

Journalism in the Public Interest

Cancel
Health Care

Explore $2 Billion in Drug Company Payments to Physicians

blog comments powered by Disqus

Projects You Can Help With

.

Join Our Reporting Network for Updates on Ways to ‘Get Involved’

Sign Up

6459 signed up

.

Meet Our New Comments System – Where You Can Share Your Stories, Too

Learn More

.

Discussion: Why Medicare Wastes Billions on Name-Brand Drugs

Read Transcript

48 posts

.

What’s Your Obamacare Story? Help ProPublica Cover the Affordable Care Act

Share

268 Stories Shared

More on This Investigation

Why Pharma Payments to Doctors Were So Hard to Parse

Flaws in information submitted to Open Payments, a government database of financial relationships in the medical field, complicated our analysis.

Vying for Market Share, Companies Heavily Promote ‘Me Too’ Drugs

Our comprehensive analysis of drug company spending on doctors in the last five months of 2013 shows the most-promoted products typically were not cures, breakthroughs or top sellers.

Dollars for Dudes: Almost No Women Among Medical Industry’s Top-Paid Speakers, Consultants

The causes are not clear, but men account for more than 90 percent of the 300 doctors who received the most money from drug and medical device companies, according to new federal data.

$1.1 Billion in Drug, Device Payments to Doctors Not Included in New Federal Database

The new Open Payments database of industry payments to doctors and teaching hospitals is more incomplete than previously known.

Analysis: Government’s New Doctor Payments Website Worthy of a Recall

Our health reporter Charles Ornstein takes a test drive using the federal government's new website for drug and device payments. He finds it virtually unusable.